Calico (company)
American research and development company
Calico LLC is an American research and development company founded in 2013 by Google and Arthur D. Levinson. The company focuses on the study of aging and associated diseases, with the aim of extending the human lifespan.
History
Calico was announced on September 18, 2013, by Larry Page, then CEO of Google, in a post on the official Google blog. The company was established as a subsidiary of Alphabet Inc., Google's parent company, and is headquartered in South San Francisco, California.
The name "Calico" is an abbreviation of "California Life Company." The company was founded with the mission to "harness advanced technologies to increase our understanding of the biology that controls lifespan."
Research Focus
Calico's research is primarily focused on understanding the biological mechanisms of aging and developing interventions to address age-related diseases. The company employs a multidisciplinary approach, combining genomics, bioinformatics, and molecular biology to explore the underlying causes of aging.
Aging and Longevity
Aging is a complex biological process that involves the gradual deterioration of cellular and molecular functions. Calico aims to identify the genetic and environmental factors that contribute to aging and to develop therapies that can slow down or reverse these processes.
Calico's research also targets diseases that are prevalent in older populations, such as cancer, neurodegenerative diseases, and cardiovascular diseases. By understanding the common pathways that lead to these conditions, Calico hopes to develop treatments that can improve healthspan as well as lifespan.
Collaborations
Calico has established several partnerships with leading academic institutions and biotechnology companies to advance its research. Notable collaborations include partnerships with AbbVie, a global biopharmaceutical company, to develop and commercialize new therapies for age-related diseases.
Leadership
The company is led by Arthur D. Levinson, who serves as the CEO. Levinson is a prominent figure in the biotechnology industry, having previously served as the CEO of Genentech.
Facilities
Calico's research facilities are located in South San Francisco, where the company conducts its laboratory and clinical research. The facilities are equipped with state-of-the-art technology to support its scientific endeavors.
Related pages
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD